Trinity Biotech plc Long-term Investment Intensity
Trinity Biotech plc long-term investment intensity. Trinity Biotech plc (TRIB) has a Long-term Investment Intensity of 2.6% as of December 2025. Long-term investments of $2.77 Million represent 2.6% of total assets of $105.17 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See working capital to net assets of Trinity Biotech plc to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Trinity Biotech plc (2014–2025)
Long-term investment intensity of Trinity Biotech plc from 2014 to 2025. This chart shows how Trinity Biotech plc's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2025. As of December 2025, the intensity stands at 2.6%, reflecting long-term investments of $2.77 Million against total assets of $105.17 Million USD. See Trinity Biotech plc (TRIB) liquidity interval to measure how many days the company can operate on defensive assets alone.
Trinity Biotech plc Long-term Investment Intensity by Year (2014–2025)
Trinity Biotech plc long-term investment intensity by year from 2014 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Trinity Biotech plc from 2014 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Trinity Biotech plc (TRIB) total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 2.6% | $2.77 Million | $105.17 Million | ▲ +0.3 pp |
| 2024 | 2.4% | $2.46 Million | $103.29 Million | ▲ +2.2 pp |
| 2017 | 0.2% | $360.00K | $192.62 Million | ▼ -1.1 pp |
| 2015 | 1.3% | $4.69 Million | $358.96 Million | ▼ -0.6 pp |
| 2014 | 1.9% | $4.69 Million | $242.84 Million | — |